142 related articles for article (PubMed ID: 11485550)
1. Overexpression of matrix metalloproteinase-2 mediates phenotypic transformation of lens epithelial cells.
Seomun Y; Kim J; Lee EH; Joo CK
Biochem J; 2001 Aug; 358(Pt 1):41-8. PubMed ID: 11485550
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor-beta in transdifferentiation and fibrosis of lens epithelial cells.
Lee EH; Joo CK
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2025-32. PubMed ID: 10440257
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.
Fan JM; Ng YY; Hill PA; Nikolic-Paterson DJ; Mu W; Atkins RC; Lan HY
Kidney Int; 1999 Oct; 56(4):1455-67. PubMed ID: 10504497
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the transforming growth factor-beta-inducible gene betaig-h3 in anterior polar cataracts.
Lee EH; Seomun Y; Hwang KH; Kim JE; Kim IS; Kim JH; Joo CK
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1840-5. PubMed ID: 10845607
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation.
Nathu Z; Dwivedi DJ; Reddan JR; Sheardown H; Margetts PJ; West-Mays JA
Exp Eye Res; 2009 Feb; 88(2):323-30. PubMed ID: 18809398
[TBL] [Abstract][Full Text] [Related]
6. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
[TBL] [Abstract][Full Text] [Related]
7. [Expression and significance of transforming growth factor-beta1, matrix metalloproteinase-2 and its inhibitor in lens epithelial cells of diabetic cataract].
Xu GX; Hu JZ; Zheng WD; Zhang S; Wang TT
Zhonghua Yan Ke Za Zhi; 2003 Jul; 39(7):411-4. PubMed ID: 12921671
[TBL] [Abstract][Full Text] [Related]
8. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
9. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.
Cheng S; Lovett DH
Am J Pathol; 2003 Jun; 162(6):1937-49. PubMed ID: 12759250
[TBL] [Abstract][Full Text] [Related]
10. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
Han SY; Jee YH; Han KH; Kang YS; Kim HK; Han JY; Kim YS; Cha DR
Nephrol Dial Transplant; 2006 Sep; 21(9):2406-16. PubMed ID: 16728425
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells.
Gupta M; Korol A; West-Mays JA
Mol Vis; 2013; 19():1017-28. PubMed ID: 23687438
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin regulates expressions of transforming growth factor-beta1 and beta1-induced matrix metalloproteinase-2 in hepatic stellate cells.
Wang Y; Zhang JS; Qian J; Huang GC; Chen Q
Int J Exp Pathol; 2006 Jun; 87(3):177-84. PubMed ID: 16709226
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
Kim ES; Kim MS; Moon A
Int J Oncol; 2004 Nov; 25(5):1375-82. PubMed ID: 15492828
[TBL] [Abstract][Full Text] [Related]
14. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.
Li Y; Yang J; Dai C; Wu C; Liu Y
J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 short hairpin RNA inhibits renal allograft fibrosis.
Yin ZK; Wu XH; Xia YG; Luo CL
Chin Med J (Engl); 2011 Mar; 124(5):655-63. PubMed ID: 21518553
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
17. Involvement of plasminogen activator inhibitor-1 in the pathogenesis of atopic cataracts.
Hori K; Matsuda A; Ebihara N; Imai K; Mori K; Funaki T; Watanabe Y; Nakatani S; Okada K; Matsuo O; Murakami A
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1846-51. PubMed ID: 22410565
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase inhibitors suppress transforming growth factor-beta-induced subcapsular cataract formation.
Dwivedi DJ; Pino G; Banh A; Nathu Z; Howchin D; Margetts P; Sivak JG; West-Mays JA
Am J Pathol; 2006 Jan; 168(1):69-79. PubMed ID: 16400010
[TBL] [Abstract][Full Text] [Related]
19. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
[TBL] [Abstract][Full Text] [Related]
20. Downregulated expression of ADAM9 in anterior polar cataracts.
Lim JM; Lee JH; Wee WR; Joo CK
J Cataract Refract Surg; 2002 Apr; 28(4):697-702. PubMed ID: 11955914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
